Gilead Sciences Inc Cash Flow-to-Debt Ratio
Gilead Sciences Inc cash flow-to-debt ratio. Gilead Sciences Inc (GILD) has a Cash Flow-to-Debt Ratio of 0.09x as of June 2026, meaning its operating cash flow of $3.57 Billion could theoretically repay 0% of its total liabilities ($37.62 Billion) in one year. Check Gilead Sciences Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Gilead Sciences Inc (1990–2025)
Cash flow-to-debt ratio of Gilead Sciences Inc from 1990 to 2025. Historical debt coverage capacity for Gilead Sciences Inc across 36 annual periods. Check Gilead Sciences Inc (GILD) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Gilead Sciences Inc Cash Flow-to-Debt Ratio by Year (1990–2025)
Gilead Sciences Inc cash flow-to-debt ratio by year from 1990 to 2025. Year-by-year debt coverage analysis for Gilead Sciences Inc. For the full cash flow conversion analysis, see Gilead Sciences Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | $10.02 Billion | $36.41 Billion | ▲ +1.0% |
| 2024 | 0.27x | $10.83 Billion | $39.75 Billion | ▲ +34.0% |
| 2023 | 0.20x | $8.01 Billion | $39.38 Billion | ▼ -6.0% |
| 2022 | 0.22x | $9.07 Billion | $41.96 Billion | ▼ -11.0% |
| 2021 | 0.24x | $11.38 Billion | $46.89 Billion | ▲ +49.2% |
| 2020 | 0.16x | $8.17 Billion | $50.19 Billion | ▼ -30.6% |
| 2019 | 0.23x | $9.14 Billion | $38.98 Billion | ▲ +17.7% |
| 2018 | 0.20x | $8.40 Billion | $42.14 Billion | ▼ -16.6% |
| 2017 | 0.24x | $11.90 Billion | $49.78 Billion | ▼ -47.3% |
| 2016 | 0.45x | $17.05 Billion | $37.61 Billion | ▼ -30.2% |
| 2015 | 0.65x | $21.25 Billion | $32.73 Billion | ▼ -4.5% |
| 2014 | 0.68x | $12.82 Billion | $18.84 Billion | ▲ +137.3% |
| 2013 | 0.29x | $3.10 Billion | $10.83 Billion | ▲ +4.9% |
| 2012 | 0.27x | $3.19 Billion | $11.70 Billion | ▼ -21.7% |
| 2011 | 0.35x | $3.64 Billion | $10.44 Billion | ▼ -32.7% |
| 2010 | 0.52x | $2.83 Billion | $5.47 Billion | ▼ -46.3% |
| 2009 | 0.96x | $3.08 Billion | $3.19 Billion | ▲ +11.2% |
| 2008 | 0.87x | $2.14 Billion | $2.47 Billion | ▲ +9.8% |
| 2007 | 0.79x | $1.77 Billion | $2.23 Billion | ▲ +43.8% |
| 2006 | 0.55x | $1.22 Billion | $2.22 Billion | ▼ -42.5% |
| 2005 | 0.96x | $705.64 Million | $738.54 Million | ▼ -46.4% |
| 2004 | 1.78x | $507.96 Million | $285.09 Million | ▲ +319.0% |
| 2003 | 0.43x | $234.61 Million | $551.75 Million | ▲ +309.6% |
| 2002 | 0.10x | $74.41 Million | $716.84 Million | ▲ +128.0% |
| 2001 | -0.37x | $-126.98 Million | $342.35 Million | ▼ -217.5% |
| 2000 | -0.12x | $-38.20 Million | $326.98 Million | ▲ +74.0% |
| 1999 | -0.45x | $-62.60 Million | $139.52 Million | ▼ -34.8% |
| 1998 | -0.33x | $-51.30 Million | $154.10 Million | ▲ +78.7% |
| 1997 | -1.57x | $-54.50 Million | $34.80 Million | ▼ -80.3% |
| 1996 | -0.87x | $-16.50 Million | $19.00 Million | ▲ +42.6% |
| 1995 | -1.51x | $-23.00 Million | $15.20 Million | ▲ +10.0% |
| 1994 | -1.68x | $-27.40 Million | $16.30 Million | ▲ +15.2% |
| 1993 | -1.98x | $-22.40 Million | $11.30 Million | ▼ -64.8% |
| 1992 | -1.20x | $-8.90 Million | $7.40 Million | ▼ -0.8% |
| 1991 | -1.19x | $-3.70 Million | $3.10 Million | ▼ -14.4% |
| 1990 | -1.04x | $-2.40 Million | $2.30 Million | — |